A randomized, double-blind, placebo-controlled study to evaluate the analgesic efficacy, safety and tolerability of ALGRX 4975 in subjects after inguinal hernia repair.

Trial Profile

A randomized, double-blind, placebo-controlled study to evaluate the analgesic efficacy, safety and tolerability of ALGRX 4975 in subjects after inguinal hernia repair.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2012 Planned number of patients changed from 40 to 100 as reported by European Clinical Trials Database record.
    • 01 Jul 2008 Primary endpoint not achieved; results published in Anesthesia and Analgesia.
    • 17 Oct 2007 Results reported at the 2007 Annual Meeting of the American Society of Anesthesiologists.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top